Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tegtociclib (PF-07104091)
i
Other names:
PF-07104091, PF 07104091, PF07104091
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer
Drug class:
CDK2 inhibitor
Related drugs:
‹
BLU-222 (4)
INX-315 (2)
AVZO-021 (0)
FN-1501 (0)
GW8510 (0)
RLY-2139 (0)
BLU-222 (4)
INX-315 (2)
AVZO-021 (0)
FN-1501 (0)
GW8510 (0)
RLY-2139 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
PF-07104091
Sensitive: C2 – Inclusion Criteria
PF-07104091
Sensitive
:
C2
PF-07104091
Sensitive: C2 – Inclusion Criteria
PF-07104091
Sensitive
:
C2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.